Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (91-100 of 190) with videos related to

Pageof 19
Sort By:
Insights Into Imaging|November 17, 2017
Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphologyAnnemie Snoeckx, Pieter Reyntiens, Damien Desbuquoit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Cancers|August 12, 2023
Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology PatientsKurt G Tournoy, Valerie Adam, Inge Muylle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?Gijsbert W P M Kramer, Steven Gans, Eric Ullmann, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaRob J van Klaveren, Joachim G J V Aerts, Hein de Bruin, et al.
Insights Into Imaging|April 13, 2018
Imaging of urgencies and emergencies in the lung cancer patientBruno De Potter, Jef Huyskens, Birgitta Hiddinga, et al.
Familial Cancer|July 2, 2018
Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesotheliomaMarieke Hylebos, Ken Op de Beeck, Jenneke van den Ende, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
Frontiers in Oncology|May 23, 2022
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath ResearchEline Janssens, Zoë Mol, Lore Vandermeersch, et al.
Translational Lung Cancer Research|November 20, 2018
Extrapleural pneumonectomy: still indicated?Andreas Domen, Lawek Berzenji, Jeroen M H Hendriks, et al.
Pageof 19

Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Insights Into Imaging|November 17, 2017
Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphologyAnnemie Snoeckx, Pieter Reyntiens, Damien Desbuquoit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Cancers|August 12, 2023
Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology PatientsKurt G Tournoy, Valerie Adam, Inge Muylle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?Gijsbert W P M Kramer, Steven Gans, Eric Ullmann, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesotheliomaRob J van Klaveren, Joachim G J V Aerts, Hein de Bruin, et al.
Insights Into Imaging|April 13, 2018
Imaging of urgencies and emergencies in the lung cancer patientBruno De Potter, Jef Huyskens, Birgitta Hiddinga, et al.
Familial Cancer|July 2, 2018
Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesotheliomaMarieke Hylebos, Ken Op de Beeck, Jenneke van den Ende, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2015
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, et al.
Frontiers in Oncology|May 23, 2022
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath ResearchEline Janssens, Zoë Mol, Lore Vandermeersch, et al.
Translational Lung Cancer Research|November 20, 2018
Extrapleural pneumonectomy: still indicated?Andreas Domen, Lawek Berzenji, Jeroen M H Hendriks, et al.
Pageof 19